Related references
Note: Only part of the references are listed.Burden of illness in painful diabetic peripheral neuropathy: The patients' perspectives
Mugdha Gore et al.
JOURNAL OF PAIN (2006)
Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial
R van Seventer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Pregabalin drug interaction studies: Lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy
MJ Brodie et al.
EPILEPSIA (2005)
Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens
R Freynhagen et al.
PAIN (2005)
Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy
DC Zelman et al.
PAIN (2005)
Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial
RW Richter et al.
JOURNAL OF PAIN (2005)
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations
RH Dworkin et al.
PAIN (2005)
Practice parameter: Treatment of postherpetic neuralgia an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology
RM Dubinsky et al.
NEUROLOGY (2004)
Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial
J Rosenstock et al.
PAIN (2004)
Pregabalin relieves symptoms of painful diabetic neuropathy - A randomized controlled trial
H Lesser et al.
NEUROLOGY (2004)
Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia:: results of a randomised, placebo-controlled clinical trial
R Sabatowski et al.
PAIN (2004)
Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale
JT Farrar et al.
PAIN (2001)